Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.11
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.03 (27.273%)
Open: 0.125
High: 0.125
Low: 0.125
Prev. Close: 0.125
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jul 2017 11:10

RNS Number : 4378M
Deltex Medical Group PLC
28 July 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DELTEX MEDICAL GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: MISSED DISCLOSURE DUE TO SHARES IN ISSUE CHANGE

3. Details of person subject to the notification obligationiv

Name

J O HAMBRO CAPITAL MANAGEMENT LIMITED

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27 JULY 2017

6. Date on which issuer notified (DD/MM/YYYY):

28 JULY 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.72%

0.00%

9.72%

313,115,807

Position of previous notification (if

applicable)

10.68%

0.00%

10.68%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0059337583

30,419,696

9.72%

SUBTOTAL 8. A

30,419,696

9.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

-

The number and % of voting rights held

-

The date until which the voting rights will be held

-

11. Additional informationxvi

.

 

 

Place of completion

J O HAMBRO CAPITAL MANAGEMENT, LONDON

Date of completion

28 JULY 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXPAELXEFF
Date   Source Headline
1st Dec 20144:10 pmRNSDirector/PDMR Shareholding
13th Nov 20147:00 amRNSPatent granted for flexible Doppler probes
5th Nov 20147:00 amRNSPremier Fluid Data Presented at US Conference
21st Oct 20147:00 amRNSHolding(s) in Company
8th Oct 20143:55 pmRNSHolding(s) in Company
8th Oct 20147:00 amRNSDirector/PDMR Shareholding
29th Sep 20141:35 pmRNSInvestor Presentation
11th Sep 20147:00 amRNSEvidence Update
11th Sep 20147:00 amRNSInterim Results
3rd Sep 20147:00 amRNSNew US Account and Notice of Results
14th Jul 20147:00 amRNSPre-close Update
1st Jul 20144:27 pmRNSDirector/PDMR Shareholding
1st Jul 20147:00 amRNSAdditional Listing
26th Jun 20147:00 amRNSDirector/PDMR Shareholding
25th Jun 20147:00 amRNSDirector Share Purchase
19th Jun 201411:00 amRNSDirector/PDMR Shareholding
18th Jun 20147:00 amRNSIncrease in physician payment level in the USA
17th Jun 20147:00 amRNSBoard Changes
11th Jun 201410:15 amRNSHolding(s) in Company
10th Jun 20148:01 amRNSDirector/PDMR Shareholding
9th Jun 20144:22 pmRNSResult of Open Offer
9th Jun 201411:01 amRNSPlacing and Open Offer - Result of General Meeting
4th Jun 20147:00 amRNSAdditional Dedicated Trainer Account in USA
23rd May 20141:48 pmRNSPosting of Circular
22nd May 20147:00 amRNSConditional Placing and Open Offer
7th May 201412:45 pmRNSResult of AGM
7th May 20147:00 amRNSAGM Statement
11th Apr 20147:00 amRNSBoard Changes
2nd Apr 20147:00 amRNSNHS England implementation plan update
26th Mar 20147:00 amRNSNHS Supply Chain Update
11th Mar 20147:00 amRNSRelease of oesophageal Doppler patient simulator
11th Mar 20147:00 amRNSFinal Results
28th Jan 20147:00 amRNSDistribution Agreement
14th Jan 20147:00 amRNSParis Tender Renewal & New Dedicated Trainer in US
9th Jan 20147:00 amRNSPre-Close Update
31st Dec 20137:00 amRNSIssue of Equity
24th Dec 201311:52 amRNSHolding(s) in Company
23rd Dec 20131:45 pmRNSGrant of Options
23rd Dec 20131:40 pmRNSIssue of Equity
23rd Dec 201311:30 amRNSDirector/PDMR Shareholding
19th Dec 201312:00 pmRNSFirst Results from Premier Study
19th Dec 20137:00 amRNSPublication of evidence review
17th Dec 20139:55 amRNSHolding(s) in Company
12th Dec 20137:00 amRNSJoint Venture in Canada
28th Nov 20137:00 amRNSFourth Dedicated Trainer Hospital in USA
22nd Nov 20135:57 pmRNSAdditional Listing
31st Oct 201312:00 pmRNSAdditional Listing
28th Oct 20133:27 pmRNSHolding(s) in Company
25th Oct 20133:01 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSAdditional Dedicated Trainer Hospital in USA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.